Eric Bjerkholt

CHIEF FINANCIAL OFFICER

Eric Bjerkholt (CHIEF FINANCIAL OFFICER) filed 7 Form 4 reports in the trailing twelve months (0 purchases, 7 sales), most often in Mirum Pharmaceuticals, Inc. (MIRM). The largest single filing was $978K of MIRM (9,943 sh × $98.37, as filed), executed Sep 14.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 7 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$3.5M

shares × price, as filed

Last traded

Sep 14

Filed Sep 15

Median ADV $83.1M across their filed names

Open performance→

Volume by month

Buys $0 Sells $4.7M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 7 filings

Sector per market data · by filing · past 12 months

Most traded names

MIRM

Mirum Pharmaceuticals, Inc. MIRM · 0 buys · 9 sells 9 filings

Recent filings

MIRMSALE Mirum Pharmaceuticals, Inc. View filing → $978K
9,943 sh × $98.37
Exec Sep 14
Filed Sep 15 · 4:10 PM ET MIRMSALE Mirum Pharmaceuticals, Inc. View filing → $600K
6,001 sh × $99.90
Exec Aug 11
Filed Aug 12 · 5:14 PM ET MIRMSALE Mirum Pharmaceuticals, Inc. View filing → $508K
4,172 sh across 2 lots
Exec Jul 6
Filed Jul 8 · 5:07 PM ET MIRMSALE Mirum Pharmaceuticals, Inc. View filing → $469K
5,000 sh across 3 lots
Exec Jun 8
Filed Jun 9 · 5:30 PM ET MIRMSALE Mirum Pharmaceuticals, Inc. View filing → $670K
7,287 sh × $91.98
Exec Mar 16
Filed Mar 17 · 5:30 PM ET MIRMSALE Mirum Pharmaceuticals, Inc. View filing → $101K
1,053 sh × $96.19
Exec Jan 26
Filed Jan 27 · 5:30 PM ET MIRMSALE Mirum Pharmaceuticals, Inc. View filing → $133K
1,421 sh × $93.33
Exec Jan 22
Filed Jan 23 · 5:30 PM ET MIRMSALE Mirum Pharmaceuticals, Inc. View filing → $728K
9,578 sh × $76.01
Exec Sep 12 2025
Filed Sep 12 2025 · 5:30 PM ET More filings →